EMJ Oncology 11 [Supplement 1] . 2023

Journal Info

This article reviews key updates on ovarian cancer research that were presented at the European Society for Medical Oncology (ESMO) Congress 2022. Rising global incidence, high relapse rates, and poor prognoses have highlighted the need for improved survival and quality of life for patients with ovarian cancer.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?